PDX Pharmaceuticals

Pdx Pharmaceuticals

Biotechnology, 3303 S Bond Ave, Portland, Oregon, 97239, United States, 1-10 Employees

pdxpharm.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is PDX PHARMACEUTICALS

PDX Pharmaceuticals is an IND-enabling stage biopharmaceutical company. We develop novel combination and immunotherapies to treat cancer by bringing complementary biological pathways toge...

Read More

map
  • 3303 S Bond Ave, Portland, Oregon, 97239, United States Headquarters: 3303 S Bond Ave, Portland, Oregon, 97239, United States
  • 2010 Date Founded: 2010
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5122 | NAICS Code: 541110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PDX PHARMACEUTICALS

PDX Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding PDX Pharmaceuticals

Answer: PDX Pharmaceuticals's headquarters are located at 3303 S Bond Ave, Portland, Oregon, 97239, United States

Answer: PDX Pharmaceuticals's phone number is +12*********

Answer: PDX Pharmaceuticals's official website is https://pdxpharm.com

Answer: PDX Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: PDX Pharmaceuticals's SIC: 5122

Answer: PDX Pharmaceuticals's NAICS: 541110

Answer: PDX Pharmaceuticals has 1-10 employees

Answer: PDX Pharmaceuticals is in Biotechnology

Answer: PDX Pharmaceuticals contact info: Phone number: +12********* Website: https://pdxpharm.com

Answer: PDX Pharmaceuticals is an IND-enabling stage biopharmaceutical company. We develop novel combination and immunotherapies to treat cancer by bringing complementary biological pathways together to achieve synergistic clinical benefit. Our therapeutic candidates bridge the innate and adaptive immune systems by generating profound CD8+ T cell production. Our pipelines are patented AIRISE (Augmenting Immune Responses and Inhibiting the Suppressive Environment of Tumors) and ARAC (Antigen Release Agent and Checkpoint Inhibitor) pipelines that generate anti-tumor immunity when given locally (AIRISE) or systemically (ARAC) by relying on patient' s own tumor in situ as the source of antigens.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access